ArticleBMC genomics2026
High-efficiency 14-plex cSNP SNaPshot assay for forensic peripheral blood identification.
Article in BMC genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The analysis of body fluid stains found at criminal scenes requires not only DNA profiles but also identification of the composition of these stains, particularly in mixed stains. Prior studies have demonstrated that forensic body fluids can be differentiated by their mRNA biomarkers.In this study, we screened a panel including 14 cSNPs located on four peripheral blood mRNA biomarkers (CD3G, ANK1, SPTB, and GYPA) and developed a multiplex assay for forensic blood identification using the SNaPshot method. Particularly, a one-step multiplex reverse transcription PCR (RT-PCR) strategy was used to generate cDNA amplicons from the corresponding mRNA by reverse transcription. The sensitivity, specificity, and capability of the multiplex SNaPshot assay for blood identification were systematically assessed. These results showed that the panel of 14 cSNPs successfully realized peripheral blood identification, including single-source body fluid as well as mixed samples. However, several peripheral blood cSNP markers were detected at low expression levels in menstrual blood and vaginal secretions. The detection sensitivity of the multiplex assay reached 1 ng total RNA input. Furthermore, 14 cSNP loci were genotyped across 19 peripheral blood samples, yielding 100% concordance between DNA- and RNA-derived profiles. Using allele frequencies of 14 cSNP loci in 100 unrelated Han individuals from northern China, the cumulative discrimination power of the 14 cSNPs was calculated to be 0.98303.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.